Bausch & Lomb and Pharmos Corporation Have Completed Patient Enrollment in Loteprednol / Antibiotic Combination Study.
Business Wire › February 11, 1999
Linked as:
Extract
Bausch & Lomb and Pharmos Corporation Have Completed Patient Enrollment in Loteprednol / Antibiotic Combination Study.
ROCHESTER, N.Y.--(BUSINESS WIRE)--Feb. 9, 1999--
Third Product in Ophthalmic Line Begins Last Step in Development Bausch & Lomb (NYSE: BOL) and Pharmos Corporation (Nasda...See the full content of this document
Sponsored links
